Showing results (141-150 of 151) with videos related to
Sort By:
Pageof 16
European Heart Journal. Acute Cardiovascular Care|June 9, 2017
Prevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a BleeMACS substudyMario Iannaccone, Fabrizio D'Ascenzo, Paolo Vadalà, et al.Thrombosis and Haemostasis|April 4, 2018
Prediction of Post-Discharge Bleeding in Elderly Patients with Acute Coronary Syndromes: Insights from the BleeMACS RegistryAlberto Garay, Albert Ariza-Solé, Francesc Formiga, et al.Journal of the American College of Cardiology|February 11, 2022
A Score to Assess Mortality After Percutaneous Mitral Valve RepairSergio Raposeiras-Roubin, Marianna Adamo, Xavier Freixa, et al.Revista Espanola De Cardiologia (English Ed.)|May 21, 2019
Impact of renin-angiotensin system blockade on the prognosis of acute coronary syndrome based on left ventricular ejection fractionSergio Raposeiras-Roubín, Emad Abu-Assi, María Cespón-Fernández, et al.Thrombosis Research|August 2, 2018
Gender-related differences in post-discharge bleeding among patients with acute coronary syndrome on dual antiplatelet therapy: A BleeMACS sub-studyKajetan Grodecki, Zenon Huczek, Piotr Scisło, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 6, 2019
Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS RegistriesMattia Peyracchia, Andrea Saglietto, Carloalberto Biolè, et al.International Journal of Cardiology|February 7, 2018
Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS scoreSergio Raposeiras-Roubín, Jonas Faxén, Andrés Íñiguez-Romo, et al.European Heart Journal. Acute Cardiovascular Care|May 2, 2019
Incidence, predictors and prognostic impact of intracranial bleeding within the first year after an acute coronary syndrome in patients treated with percutaneous coronary interventionSergio Raposeiras-Roubín, Emad Abu-Assi, Berenice Caneiro Queija, et al.European Heart Journal. Cardiovascular Pharmacotherapy|September 13, 2019
P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projectsOvidio De Filippo, Fabrizio D'Ascenzo, Sergio Raposeiras-Roubin, et al.American Heart Journal|December 7, 2019
Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registriesFabrizio D'Ascenzo, Carloalberto Biolè, Sergio Raposeiras-Roubin, et al.Pageof 16